These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of systemic scleroderma with high dosage of intravenous hyaluronidase]. Petter O; Bellmann H Hautarzt; 1971 Jan; 22(1):32-3. PubMed ID: 4251354 [No Abstract] [Full Text] [Related]
3. [Our experience in the treatment of progressive scleroderma with hyaluronidase]. Janković D; Mladenović P; Arnerić S; Stanković K Srp Arh Celok Lek; 1975 Jun; 103(6):531-4. PubMed ID: 1209350 [No Abstract] [Full Text] [Related]
4. [Treatment with hyaluronidase in dermatology]. Wozniak KD; Braun W Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1109-10. PubMed ID: 1226845 [No Abstract] [Full Text] [Related]
5. [Gestagens in the treatment of scleroderma]. Szczepański A Przegl Dermatol; 1973; 60(4):521-3. PubMed ID: 4755917 [No Abstract] [Full Text] [Related]
6. Activation of dermal connective tissue in scleroderma. Kähäri VM Ann Med; 1993 Dec; 25(6):511-8. PubMed ID: 8292298 [TBL] [Abstract][Full Text] [Related]
7. [Theoretical aspects of the new possibilities of use of hyaluronidase]. Petter O; Bellmann H Z Gesamte Inn Med; 1971 Mar; 26(5):171-4. PubMed ID: 5560774 [No Abstract] [Full Text] [Related]
8. [Systemic sclerosis--clinical course and treatment possibilities]. Szymańska E; Maj M; Rudnicka L Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791 [TBL] [Abstract][Full Text] [Related]